decisionhealth Newsletters, Coder Pink Sheets - 2011 Issue 1 (January)
Prescriber beware – take these 6 steps to keep doctor shoppers from your door
Subscribe or sign in to view the full article.
Article Overview
This article discusses the risk of prescription drug misuse and the broader practice-management and patient-safety steps clinicians can use to respond. It covers general screening, urine testing, ongoing review of prescribing, and the role of state prescription monitoring programs, with comments from clinicians and industry representatives.
Why This Topic Matters
The topic is relevant to practices that prescribe controlled substances and want to reduce patient-safety risks, liability exposure, and misuse of prescribing resources. It is especially useful for clinicians, compliance staff, and managers involved in controlled-substance workflows and monitoring.
Article Sections
-
Introduction
Introduces the concern of prescription drug misuse and why clinicians who prescribe controlled substances may be targeted. Also frames the patient-safety and liability context for the article.
-
Six practice steps to address doctor shopping
Presents a set of practice-oriented measures for identifying risk, monitoring prescribing, and responding to possible misuse concerns. The section includes discussion of screening, testing, follow-up, and state monitoring tools.
What You Will Learn
- How prescription drug misuse can affect prescribing practices
- General approaches to screening patients for substance abuse risk
- The role of urine testing in monitoring controlled-substance use
- Why ongoing reassessment matters after an opioid is prescribed
- How state prescription monitoring programs fit into prescribing oversight
Who Should Read This
- Physicians
- Nurse practitioners
- Physician assistants
- Compliance managers
- Practice administrators
- Medical office staff involved in controlled-substance workflows
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com